Canbiola Appoints NFL Great Leonard Marshall to its Sports Advisory Board

Initial Member has been an Active Proponent for CBD

HICKSVILLE, NY, Feb. 19, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Canbiola, Inc. () (“Canbiola” or the “Company”), a developer, manufacturer and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate, gel caps, and concentrate, announced today the appointment of Leonard Marshall to its Sports Advisory Board. NFL Great Leonard Marshall has been an active voice and supporter for the lives of others, particularly children and other football players at all levels. 

 Chief Executive Officer Marco Alfonsi commented, “We are honored and thrilled to have partnered with Leonard Marshall to help increase the awareness of the benefits of CBD and our Canbiola products. Leonard is the first of many influencers we expect to add to our Sports Advisory Board as we roll out our consumer branded CBD Canbiola products, Pure Leaf Oil.”

Leonard Marshall stated, “I am proud to partner with Canbiola and endorse their CBD products and solutions to the market. Their team has developed unique CBD products to address tissue healing and chronic pain that I, as an ex-NFL player use to improve my quality of life. I look forward to increasing the awareness of Canbiola’s products to the mass consumer market.”

Leonard Marshall’s storied NFL career is matched only by his post-football commitment to contribute positively to the lives of others, particularly children and other football players at all levels. In 2017, Leonard Marshall received a nomination to the NFL Hall of Fame. As a founder of multiple nonprofits and a volunteer for dozens more, Marshall has made philanthropy and advocacy his post-NFL career. As a C.T.E. survivor, one of Marshall’s passions is serving as a player advocate to ensure that former and current NFL players have access to hemp-based cannabidiol (CBD), a neuroprotective and anti-inflammatory.

Leonard Allen Marshall Jr. (born October 22, 1961) is a former   who played twelve seasons in the  (NFL). Selected 37th overall in the , he spent the first ten seasons of his career with the  where he accumulated 79.5 sacks, ranking him third in team history. He was twice selected to the  and twice named NFL Defensive Lineman of the Year following the 1985 and 1986 seasons. He won two championships with the Giants, recording three sacks in the two  games which he played in. Marshall is most famously known for his 1991 hit on  that knocked him out of the NFC championship game, after which Montana would not play another regular season game for almost two years. After his time with the Giants, Marshall went on to play a season each for the and , then retired from football at the age of 33. He played college football at .

Marshall has been active in several business and entrepreneurial activities since retiring. He also has spent time as a football camp instructor, a football head coach, a student, a professor, and a radio broadcaster. In 2013, Marshall was diagnosed with  (CTE), a degenerative brain disease detected in a growing number of retired NFL players. Marshall has been involved with efforts to spread awareness about the issue.

About Canbiola, Inc.

Canbiola, Inc. (OTCQB: ) is a developer, manufacturer, and seller of a variety of Cannabidiol (Hemp) based products such as oils, creams, moisturizers, chews, isolate gel caps and concentrates. Canbiola has developed its own line of proprietary products as well as seeking synergistic value through acquisitions in the CBD and the medical cannabis industry. Cannabis is currently federally illegal and has legalized for medical purposes in some form in a limited number of states, but pure CBD products are legal in all 50 states. Hemp CBD is the non-psychoactive component (No THC) used for treatment of pain, inflammation, and wellness programs.  For more information about Canbiola, Inc., please visit: .

Additionally, Canbiola’s wholly owned subsidiary Pure Health Products, based in Lacey, WA, is its prime development laboratory and production facility.  Canbiola’s Duramed division has recently rolled out a durable medical device via its Doctor network to treat patients with injuries via application of an in-home SAM device.

Forward-Looking Statements

Forward-looking statements and risks and uncertainties discussed in this letter contain forward-looking statements. The words "anticipate," "believe," "estimate," "may," "intend," "expect," and similar expressions identify such forward-looking statements. Expected, actual results, performance, or achievements could differ materially from those contemplated, expressed, or implied by the forward-looking statements contained herein. Forward-looking statements are subject to a number of risks and uncertainties, including but not limited to, risks and uncertainties associated with, among other things, the impact of economic, competitive, and other factors affecting our operations, markets, products, and performance. The matters discussed herein should not be construed in any way, shape or manner of our future financial condition or stock price.

Follow  on: 

Twitter @CanbiolaHealth

Instagram @canbiola.inc or @canbiola_cbd or @canbiola_medical_cbd

LinkedIn @

Investors and Media:



(516) 595-9544

Hayden IR



(917) 658-7878